Effect of granulocyte colony-stimulating factor on toxicities after CAR T cell therapy for lymphoma and myeloma - Quiz - MDSpire

Effect of granulocyte colony-stimulating factor on toxicities after CAR T cell therapy for lymphoma and myeloma

  • By

  • Kevin Charles Miller

  • Patrick Connor Johnson

  • Jeremy S. Abramson

  • Jacob D. Soumerai

  • Andrew J. Yee

  • Andrew R. Branagan

  • Elizabeth K. O’Donnell

  • Anna Saucier

  • Caron A. Jacobson

  • Matthew J. Frigault

  • Noopur S. Raje

  • November 1, 2022

  • 0 min

Share

Original Source(s)

Effect of granulocyte colony-stimulating factor on toxicities after CAR T cell therapy for lymphoma and myeloma

  • by Kevin Charles Miller, Patrick Connor Johnson, Jeremy S. Abramson, Jacob D. Soumerai, Andrew J. Yee, Andrew R. Branagan, Elizabeth K. O’Donnell, Anna Saucier, Caron A. Jacobson, Matthew J. Frigault, Noopur S. Raje

  • November 1, 2022

Related Content

Using period analysis to timely provide serial data on long-term survival for patients with hematological malignancies from Taizhou, Eastern China

Unexpected Resolution of Stage IV Diffuse Large B-Cell Lymphoma in an HIV-Positive Patient: A Case Study and Review of Existing Literature

Enterocolitis Associated with Immune Effector Cells Following BCMA-Targeted CAR T-Cell Therapy: Findings from a Multicenter Case Series